153 related articles for article (PubMed ID: 21529885)
1. Effects of selected pharmaceutically active compounds on treatment performance in sequencing batch reactors mimicking wastewater treatment plants operations.
Wang S; Gunsch CK
Water Res; 2011 May; 45(11):3398-406. PubMed ID: 21529885
[TBL] [Abstract][Full Text] [Related]
2. Effects of selected pharmaceutically active compounds on the ammonia oxidizing bacterium Nitrosomonas europaea.
Wang S; Gunsch CK
Chemosphere; 2011 Jan; 82(4):565-72. PubMed ID: 20980043
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
Ying GG; Kookana RS; Kolpin DW
J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
[TBL] [Abstract][Full Text] [Related]
4. Microbial ecology and performance of ammonia oxidizing bacteria (AOB) in biological processes treating petrochemical wastewater with high strength of ammonia: effect of Na(2)CO(3) addition.
Whang LM; Yang KH; Yang YF; Han YL; Chen YJ; Cheng SS
Water Sci Technol; 2009; 59(2):223-31. PubMed ID: 19182331
[TBL] [Abstract][Full Text] [Related]
5. Removal of acidic pharmaceuticals within a nitrifying recirculating biofilter.
Krkošek WH; Payne SJ; Gagnon GA
J Hazard Mater; 2014 May; 273():85-93. PubMed ID: 24727009
[TBL] [Abstract][Full Text] [Related]
6. Distributions and activities of ammonia oxidizing bacteria and polyphosphate accumulating organisms in a pumped-flow biofilm reactor.
Wu G; Nielsen M; Sorensen K; Zhan X; Rodgers M
Water Res; 2009 Oct; 43(18):4599-609. PubMed ID: 19656544
[TBL] [Abstract][Full Text] [Related]
7. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization.
Fernández C; González-Doncel M; Pro J; Carbonell G; Tarazona JV
Sci Total Environ; 2010 Jan; 408(3):543-51. PubMed ID: 19889447
[TBL] [Abstract][Full Text] [Related]
9. Removal of pharmaceutically active compounds in nitrifying-denitrifying plants.
Suárez S; Ramil M; Omil F; Lema JM
Water Sci Technol; 2005; 52(8):9-14. PubMed ID: 16312946
[TBL] [Abstract][Full Text] [Related]
10. Microbial community response during the treatment of pharmaceutically active compounds (PhACs) in constructed wetland mesocosms.
Yan Q; Min J; Yu Y; Zhu Z; Feng G
Chemosphere; 2017 Nov; 186():823-831. PubMed ID: 28826130
[TBL] [Abstract][Full Text] [Related]
11. Upflow anaerobic sludge blanket reactor--a review.
Bal AS; Dhagat NN
Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
Strenn B; Clara M; Gans O; Kreuzinger N
Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
[TBL] [Abstract][Full Text] [Related]
13. Effects of pharmaceutically active compounds on a mixed microbial community originating from a municipal wastewater treatment plant.
Wang S; Holzem RM; Gunsch CK
Environ Sci Technol; 2008 Feb; 42(4):1091-5. PubMed ID: 18351077
[TBL] [Abstract][Full Text] [Related]
14. Enrichment of nitrifying microbial communities from shrimp farms and commercial inocula.
Paungfoo C; Prasertsan P; Intrasungkha N; Blackall LL; Bhamidimarri R
Water Sci Technol; 2003; 48(8):143-50. PubMed ID: 14682581
[TBL] [Abstract][Full Text] [Related]
15. Role of biodegradation in the removal of pharmaceutically active compounds with different bulk organic matter characteristics through managed aquifer recharge: batch and column studies.
Maeng SK; Sharma SK; Abel CD; Magic-Knezev A; Amy GL
Water Res; 2011 Oct; 45(16):4722-36. PubMed ID: 21802106
[TBL] [Abstract][Full Text] [Related]
16. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
17. Effects of solids retention time on the performance of bioreactors bioaugmented with a 17β-estradiol-utilizing bacterium, Sphingomonas strain KC8.
Roh H; Chu KH
Chemosphere; 2011 Jun; 84(2):227-33. PubMed ID: 21543102
[TBL] [Abstract][Full Text] [Related]
18. Pandemic pharmaceutical dosing effects on wastewater treatment: no adaptation of activated sludge bacteria to degrade the antiviral drug oseltamivir (Tamiflu®) and loss of nutrient removal performance.
Slater FR; Singer AC; Turner S; Barr JJ; Bond PL
FEMS Microbiol Lett; 2011 Feb; 315(1):17-22. PubMed ID: 21133989
[TBL] [Abstract][Full Text] [Related]
19. Linking microbial diversity and population dynamics to the removal efficiency of pharmaceutically active compounds (PhACs) in an anaerobic/anoxic/aerobic (A
Gallardo-Altamirano MJ; Maza-Márquez P; Montemurro N; Rodelas B; Osorio F; Pozo C
Chemosphere; 2019 Oct; 233():828-842. PubMed ID: 31200141
[TBL] [Abstract][Full Text] [Related]
20. Nitrification activity and community structure of nitrite-oxidizing bacteria in the bioreactors operated with addition of pharmaceuticals.
Kraigher B; Mandic-Mulec I
J Hazard Mater; 2011 Apr; 188(1-3):78-84. PubMed ID: 21316843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
